Search

everythinglearnresearchcommunity

for

Search:↓

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Baricitinib is effective and safe for treating severe alopecia areata.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Zinc supplements may be needed to treat hair loss in hypothyroidism.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

New alopecia treatments aim for better results and fewer side effects.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Reflectance confocal microscopy confirms that yellow dots are signs of damaged hair follicles in alopecia areata.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Iron deficiency is not a significant cause of hair loss in women.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.